Travis Kemp, MD
Foot and Ankle Surgery · Boise, IDNPI 1669607172
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,750 of the $6,875 with a category attached, or 83.6%. Zimmer Biomet accounts for 72.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $5,000 and has fallen 97.5% since, to $124 in 2023.
Across 13 payments — averaging $528.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$5K
- International Life Sciences$750
- Steelhead Surgical Inc$691
- Stryker$225
- Linvatec Corporation$124
- Johnson & Johnson$44
- plus $42 from 1 others
Across 3 payments — averaging $19,643 each. An ownership or investment interest held by the physician or an immediate family member.
- Alafair Biosciences, Inc.$59K
What the payments were for
- Consulting fees$5,75084%
- Food & beverage$4346%
- Education$69110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 3 | $5,000 |
| International Life Sciences | 1 | $750 |
| Steelhead Surgical Inc | 1 | $691 |
| Stryker(2 entities) | 3 | $225 |
| Linvatec Corporation | 1 | $124 |
| Johnson & Johnson | 2 | $44 |
| Amgen | 2 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLEXBAND$750
- ACCULIF$143
- ALLOGRAFT TISSUE$124
- COLINK PLATING SYSTEM$124
- IN2BONES USA$124
How this compares
$6,875 in reported general payments places this provider in the 70th percentile of 49 foot and ankle surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Boise
- Kaitlin NearyBoise$867K
- Steven RoserBoise$102K
- Ryan KempBoise$8K
- David ZarkouBoise$6K
- Christopher DesutterBoise$4K
- Scott BirdBoise$3K
- Boyd AndrewsBoise$2K
- Robert SwensenBoise$781
- Dan RobinsonBlackfoot$170K
- Kurt KinghornMeridian$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.